Repligen | RGEN - Ordinary Share Capital

Repligen reported $556K in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Agilent A:US USD 3M 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Catalent CTLT:US USD 2M 0
Charles River Laboratories CRL:US USD 509K 1000
Danaher DHR:US USD 9M 0
Dentsply International XRAY:US USD 3M 0
Exact Sciences EXAS:US USD 1.78M 6K
Fluidigm FLDM:US USD 80K 1000
Henry Schein HSIC:US USD 1000K 0
IQVIA Holdings Inc IQV:US USD 2.56M 436K
Myriad Genetics MYGN:US USD 800K 0
Nanostring Technologies NSTG:US USD 5K 0
Orasure Technologies OSUR:US USD 0 0
Pacific Biosciences Of California PACB:US USD 227K 1000
Patterson Companies PDCO:US USD 977K 7K
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Repligen RGEN:US USD 556K 1000